AzTrials
AzTrials

Clinical Decision MakingVRNCT07663851

EFFECTIVENESS OF VIRTUAL REALITY SIMULATION

A study testing Virtual Reality Simulation in people with Clinical Decision Making, run by Istanbul Arel University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial aims to evaluate the effects of VRS on decision-making skills, self-confidence levels, and anxiety of psychiatric nursing students. Students participating in the study will be divided into two groups: intervention and control groups. Read more about this study

Who is it for?
Ages 18 to 23 yearsHealthy volunteers can take part
Conditions the study is for
Clinical Decision Making
What is being tested?
Virtual Reality Simulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Mar 2026to 1 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 23 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • To be registered for the Psychiatric Nursing course in the 2024-2025 spring semester,
  • To be taking the Psychiatric Nursing course for the first time,
  • To attend the course regularly,
  • Not to have received any training with virtual reality simulation within the scope of the Psychiatric Nursing course before,
  • Not to have practiced in a Mental Health and Diseases clinic before

Who cannot join

  • Not registered for a Psychiatric Nursing course.
  • Having previously taken a Psychiatric Nursing course.
  • Not attending class regularly.
  • Having previously received training with a schizophrenia simulation.
  • Having previously practiced in a Mental Health and Diseases clinic.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Arzu DİKİCİ, Dr. contact

0530 037 21 80

arzudikici@arel.edu.tr

Turkey (Türkiye)1 site, 1 recruiting
  • Istanbul Arel University

    Istanbul

    Arzu Dikici, PhD

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effectiveness of Virtual Reality Simulation in Psychiatric Nursing Students and Its Impact on Their Confidence and Anxiety Levels in Clinical Decision-Making: A Randomized Controlled Study

This randomized controlled trial aims to evaluate the effects of VRS on decision-making skills, self-confidence levels, and anxiety of psychiatric nursing students. Students participating in the study will be divided into two groups: intervention and control groups. VRS, which includes a scenario of a patient with schizophrenia, will be applied to the intervention group at the beginning of the academic term, before students start clinical practice, and in the middle of the term. The control group will be subjected to theoretical courses and clinical practice. Data will be collected using the Clinical Decision-Making, Self-Confidence, and Anxiety Scale, Personal Information Form, and Modified Simulation Effectiveness Tool. Measurements will be performed at three time points: before the simulation, in the middle of the academic term, and at the end of the academic term. In addition, debriefing sessions will be held with students participating in VRS in groups of 4-5 within the scope of the simulation process. It is expected that the findings obtained as a result of the study will make significant contributions to the literature in understanding the effects of VRS on psychiatric nursing education. At the same time, this study aims to demonstrate that this VRS, designed specifically for the Turkish language and culture, can be an effective tool to increase the self-confidence levels of psychiatric nursing students in their clinical decision-making processes and to reduce their anxiety levels within the scope of the psychiatric nursing course. The results of the study are intended to guide the development of new approaches to the use of technology in psychiatric nursing education and the integration of technology-based VRS into the psychiatric nursing curriculum.

Read the detailed description

This randomized controlled trial aims to investigate the impact of a schizophrenia-focused virtual reality simulation (VRS) on clinical decision-making skills. This randomized controlled trial aims to investigate the impact of a schizophrenia-focused virtual reality simulation (VRS) on clinical decision-making skills, self-confidence, and anxiety levels of undergraduate psychiatric nursing students. The study will be conducted with second- or third-year nursing students enrolled in a psychiatric nursing course at a university in Türkiye.

Participants will be randomly assigned to either the intervention or control group. The intervention group will participate in VRS, which includes an interactive, gamified simulation scenario based on a patient diagnosed with schizophrenia. This simulation will be conducted twice: once at the beginning of the academic term, prior to clinical placement, and again at mid-term. Each simulation session will be followed by structured debriefing sessions held in small groups (4-5 students), led by a trained facilitator to enhance reflective learning and reinforce clinical reasoning.

The control group will receive standard psychiatric nursing education, consisting of theoretical lectures and routine clinical practice, without exposure to VRS.

Data will be collected using the Clinical Decision-Making Scale, Self-Confidence Scale, Anxiety Scale, Personal Information Form, and the Modified Simulation Effectiveness Tool (SET-M). Measurements will be taken at three time points: (1) before the first VRS session or clinical practice, (2) at mid-term, and (3) at the end of the academic term.

This study is expected to contribute significantly to the understanding of how technology-enhanced, culturally tailored simulation tools affect learning outcomes in psychiatric nursing education. Specifically, it aims to demonstrate that VRS can enhance students' self-confidence in clinical decision-making and reduce their anxiety before and during psychiatric clinical placements. The findings are anticipated to guide the future integration of digital simulation technologies into psychiatric nursing curricula in Türkiye and globally.

Being tested
Virtual Reality Simulation
Keywords
virtual reality, simulation, clinical decision making, mental health nursing, students

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality SimulationOther

    Virtual reality simulation of a patient with schizophrenia

Study groups in NCT07663851
Study groupRoleWhat they receive
Virtual reality simulation of a patient with schizophreniaExperimentalVirtual reality simulation will be applied to psychiatric nursing course students. The same students will participate in the theoretical and practical training of the psychiatric nursing course
Receives: Other: Virtual Reality Simulation
Control: Standard psychiatric nursing educationNo interventionThe control group will receive standard psychiatric nursing education consisting of theoretical lectures and routine clinical practice without VRS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical decision-making skills assessed by the Clinical Decision-Making Scale

    Clinical decision-making skills of psychiatric nursing students will be measured using the Clinical Decision-Making Scale at baseline, mid-term, and end of academic term.

    Measured: Baseline, mid-term (week 8), and end of academic term (week 16)

  2. Self-confidence assessed by the Self-Confidence Scale

    Self-confidence levels of psychiatric nursing students will be measured using the Self-Confidence Scale at baseline, mid-term, and end of academic term

    Measured: Baseline, mid-term (week 8), and end of academic term (week 16)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2026
  2. Study start1 Mar 2026
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion1 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07663851
Sponsor's protocol ID
E-52857131-050.04-735125
Other IDs
Istanbul Arel University
Acronym
VR
Status last verified
Jun 2026
First submitted
21 Mar 2025
Last updated
23 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Orchid ID: https://orcid.org/0000-0003-0077-9264

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Simulation in people with Clinical Decision Making, run by Istanbul Arel University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Arzu DİKİCİ, Dr. (0530 037 21 80, arzudikici@arel.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical decision-making skills assessed by the Clinical Decision-Making Scale (time frame: Baseline, mid-term (week 8), and end of academic term (week 16)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in